`
`Drugs@FDA: FDA Approved Drug Products
`
`FDA Home3 Drug Databases4 Drugs@FDA5
`
`Drugs@FDfl
`
`FDA Approved Drug Products
`
`FAQ5 |
`
`Instructions7 | Glossarys |
`
`Contact U59
`
`Eisrnaii Link
`
`Start Over
`
`Back to Search Results
`
`Back to Overview
`
`Drug Details
`
`Drug Name(s)
`FDA Application No.
`Active Ingredient(s)
`Company
`Original Approval or Tentative Approval Date
`Chemical Type
`Review Classification
`
`VOLTAREN
`
`(NDA) 020037
`DIC LOFENAC SODIUM
`NOVAR1'IS
`
`March 28, 1991
`3 New dosage form
`P Priority review drug
`
`- Therapeutic Equivalents
`
`- Label Information
`
`- Approval History, Letters, Reviews, and Related
`Documents
`
`Products on Application (NDA) #020037
`Click on a column header to re-sort the table:
`
`Drug Name
`
`Active Ingredients
`
`Strength Dosage Form / Route
`
`VOLTAREN
`
`DICLOFENAC SODIUM
`
`0.1%
`
`SOLUTION/DROPS;OPHTHALMIC
`
`Marketing
`Status
`
`Prescription
`
`RLD TE
`Code
`Yes AT
`
`Back to Top | Back to Previous Page | Back to Drugs@FDA Home
`
`Disclaimerlo
`
`FDA/Center for Drug Evaluation and Research
`Office of Communications
`Division of Online Communications
`Update Frequency: Daily
`
`Links on this page:
`
`1. http://www.addthis.corn/bookrnark.php?u508=true&v=152&usernarne=fdarnain
`
`http://www.addthis.corn/bookrna rk.php
`
`http://www.fda.gov/default.htm
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/default . htm
`
`http://www.accessdata.fda.gov/sc ripts/cder/d rugsatfda/index.cfm
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/uc m075234. htm
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/UCM079874
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/uc m079436. htm
`
`http://www.accessdata.fda.gov/scripts/ernail/cder/comrnentdrugcat.cfm
`
`http://www.fda.gov/AboutFDA/AboutThiswebsite/WebsitePo|ic ies/default . ht m#web
`
`.‘°9°.\'?‘.”".4‘.“*’!"
`
`I- .0
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`http://vvww.accessdata.fda.g ov/scri pts/cder/drug satfda/i ndexcfm?fuseacti on= Search. D rug D etai ls
`
`LUPIN EX1032, Page 1
`
`1/2
`
`LUPIN EX1032, Page 1
`
`
`
`2/24/2014
`
`Drugs@FDA: FDA Approved Drug Products
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Email FDA
`
`D [3 Q _-.
`v
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness
`International Programs News & Events Training and Continuing Education Inspections/Compliance State & Local Officials
`Consumers Industry Health Professionals FDA Archive
`£ US. Department of Health St Human Services
`
`Links on this page:
`
`1. http://www.addthis.corn/bookrnark.php?u508=true&v=152&username=fdamain
`
`http://www.addthis.corn/bookrna rk.php
`
`http://www.fda.gov/default.htm
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/default . htm
`
`http://www.accessdata.fda.gov/sc ripts/cder/d rugsatfda/index.cfm
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/uc mO75234. htm
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/UCM079874
`
`http://www.fda.gov/Drugs/InforrnationOnDrugs/uc m079436. htm
`
`.‘°9°.\‘.°‘.”":".°*’!"
`
`http://www.accessdata.fda.gov/scripts/ernail/cder/commentdrugcat.cfm
`|—‘~ .9 http://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePo|ic ies/default . ht m#web
`
`http://vvww.accessdata.fda.g ov/scri pts/cder/drug satfda/i ndexcfm?fuseacti on= Search. D rug D etai ls
`
`LUPIN EX1032, Page 2
`
`2/2
`
`LUPIN EX1032, Page 2